Anne-christine C. Piguet

Bern, BE, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platform 6-14).

Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platform 6-14).

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: June 25, 2020

Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial.

Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 17, 2019

Hepatic gene expression in mouse models of non-alcoholic fatty liver disease after acute exercise.

Hepatic gene expression in mouse models of non-alcoholic fatty liver disease after acute exercise.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: September 06, 2018

PTEN Down-Regulation Promotes β-Oxidation to Fuel Hypertrophic Liver Growth After Hepatectomy in Mice.

PTEN Down-Regulation Promotes β-Oxidation to Fuel Hypertrophic Liver Growth After Hepatectomy in Mice.

Journal: Hepatology (Baltimore, Md.)

Published: November 18, 2016

Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer.

Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer.

Journal: Genes & cancer

Published: June 08, 2015

Regular exercise decreases liver tumors development in hepatocyte-specific PTEN-deficient mice independently of steatosis.

Regular exercise decreases liver tumors development in hepatocyte-specific PTEN-deficient mice independently of steatosis.

Journal: Journal of hepatology

Published: May 30, 2014

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.

Journal: Nature communications

Published: April 02, 2014

Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo, while demonstrating anti-angiogenic activities.

Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo, while demonstrating anti-angiogenic activities.

Journal: Clinical science (London, England : 1979)

Published: November 29, 2013

Virus-like particle-mediated intracellular delivery of mRNA cap analog with in vivo activity against hepatocellular carcinoma.

Virus-like particle-mediated intracellular delivery of mRNA cap analog with in vivo activity against hepatocellular carcinoma.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: November 06, 2013

Radiofrequency ablation suppresses distant tumour growth in a novel rat model of multifocal hepatocellular carcinoma.

Radiofrequency ablation suppresses distant tumour growth in a novel rat model of multifocal hepatocellular carcinoma.

Journal: Clinical science (London, England : 1979)

Published: July 05, 2013

Rapamycin impacts positively on longevity, despite glucose intolerance induction.

Rapamycin impacts positively on longevity, despite glucose intolerance induction.

Journal: Journal of hepatology

Published: June 06, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026